Velosity Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Velosity Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 9, 2026	Diagonal Therapeutics	$125.0M Series B	Janus Henderson Investors, Paulina Hill	Atlas Venture, Balyasny Asset Management, Biovision Ventures, BVF Partners, Checkpoint Capital, Deep Track Capital, EcoR1 Capital, Frazier Life Sciences, Lightspeed Venture Partners, Logos Capital, RA Capital Management, RV Invest, Viking Global Investors
Apr 1, 2024	Diagonal Therapeutics	$130.0M Series A	Atlas Venture, BVF Partners	Alta Partners, Double Prime LLP, Frazier Healthcare Partners, Pareto Holdings, Passion Capital, V3 Ventures, Mik Attisani, Oscar Pierre, Tom Blomfield, Checkpoint Capital, Frazier Life Sciences, Lightspeed Venture Partners, RA Capital Management, Viking Global Investors
Apr 1, 2024	Endeavor BioMedicines	$130.0M Series C	AyurMaya, Karan Takhar	Atlas Venture, Hatteras Venture Partners, Omega Funds, RA Capital, Roche Venture Fund, abrdn, Ally Bridge Group, Avidity Partners, Eckuity Capital, Fidelity Management & Research Company, Invus, Longitude Capital, Perceptive Advisors, Piper Heartland Healthcare Capital, Silver Arch Bio, SymBiosis, T. Rowe Price Associates, Woodline Partners
Sep 1, 2022	Sudo Biosciences	$37.0M Series A	Daniel Estes, Velosity Capital	5AM Ventures, Frazier Healthcare Partners
Feb 1, 2022	Koneksa Health	$45.0M Series C	Matrix Capital Management	4BIO Capital, Takeda Ventures, McKesson Ventures, Merck, Novartis, Quark Venture, Waterline Ventures
Jul 1, 2021	Wugen	$170.0M Series B	Abingworth, Bosun Hau	RiverVest, Aisling Capital, Alexandria Venture Investments, Falcon Edge Capital, Fidelity Management & Research Company, Peter Kiener, Lightchain Capital, LYZZ Capital, John McKearn, Sands Capital
Mar 22, 2021	Aura Biosciences	$80.0M Other Equity	Karan Takhar, Surveyor Capital	Adage Capital Management, Advent Life Sciences, Arix Bioscience, Chiesi Ventures, Columbus Venture Partners, Lundbeckfond Ventures, Medicxi, Rock Springs Capital, Joel Jean Mairet